N°64 - Marché /Nutrition clinique An increasingly adapted Driven by structural factors, the market for clinical nutrition, currently dominated by a handful of players, is thriving by targeting specialization and prevention. Its main growth drivers are chronic and metabolic diseases (diabetes, cardiovascular diseases) and the ageing of the population. 012 A global market driven by Asia Asia between 2015 and 2050 as compared to +31% in Europe. Estimated at $44.5 billion in 2017, the global market for clinical nutrition is expected to An offer that builds on continue its growth by 2023 at a sustained structural factors pace and a CAGR of 8% (source: Mordor intelli- gence). Infant nutrition accounts for the largestThe North American market is ranked second. share of this market (45%), namely $17 billion Nevertheless, this market is experiencing a in 2017 (ResearchAndMarkets.com’s). Asia- slight decrease while the European is experien- Pacifi c is the fi rst geographical market and was cing moderate growth. The two major growth assessed at $18.6 billion in 2017. This region isdrivers of these markets is the increase in the expected to reach the highest CAGR, namely number of chronic and metabolic diseases 6.94%. It is the Chinese market, estimated (cancer, diabetes, metabolic syndrome, stea- at $7.2 billion in 2017, that leads the growth. tohepatitis, hypercholesterolemia...) and the India, which experiences the fastest growth, is ageing of the population. The WHO, which also part of this movement. This latter is mainlyindicated that globally, 387 million people due to the rapid development of the healthcare were living with diabetes in 2014, estimates sector, the emergence of the middle class, the that between 2000 and 2030, their number high birth rate in the Asia-Pacifi c countries, thewill increase by +114%. It is one of the three end of the one-child policy in China, the inci- growth drivers on which Abbott Laboratories dence of nutrition and the high rate of elderly rely, including the increase in the cases of patients in India and China. In its annual report,cardiovascular diseases and in the number of Nestlé rightfully qualifies the ageing of the patients with chronic pain. population in Asia as a growth driver, estima- The world population growth, which is expected ting that the percentage of subjects aged over to reach 8.1 billion in 2027, is the second 60 years old is expected to rise by +87% in growth driver, mainly due to the ageing of the ■ / Juillet - Août - Septembre 2018 / N°64 / L’Actualité des Ingrédients Fonctionnels & Santé